Table 2.
Anatomical and functional outcome in both the groups
| Group A ILM Peeling |
Group B ILM inverted flap |
p value | |
|---|---|---|---|
| Anatomical closure | 76.7% (n = 23/30) | 90.0% (n = 27/30) | 0.166a |
| Anatomical success i.e. Type 1 closure | 70.0% (n = 21/30) | 90.0% (n = 27/30) | 0.125b |
| Type 2 closure | 6.7% (n = 2/30) | 0 | |
| No closure | 23.3% (n = 7/30) | 10.0% (n = 3/30) | |
| 1-line improvement | 46.7% (n = 14/30) | 53.3% (n = 16/30) | 0.606a |
| 2-line improvement | 43.3% (n = 13/30) | 40.0% (n = 12/30) | 0.793a |
| Mean BCVA at 1 month | logMAR 0.68 ± 0.25 (Snellen equivalent, 20/96). |
logMAR 0.54 ± 0.19 (Snellen equivalent, 20/69) |
0.016 c |
| Mean BCVA at 6 months | logMAR 0.65 ± 0.25 (Snellen equivalent, 20/89) |
logMAR 0.53 ± 0.20 (Snellen equivalent, 20/68) |
0.060 c |
| Mean improvement in BCVA | 1.4 lines | 2.1 lines | 0.353d |
| BCVA≥20/60 | 26.7% (n = 8/30) | 23.3% (n = 7/30) | 0.766a |
ILM Internal limiting membrane, BCVA Best-corrected visual acuity, aChi-square test, bFisher’s exact test, cMann-Whitney U test, dindependent t-test, in italics - statistically significant value